According to Renaissance Capital IPO Center, “Sensus Healthcare, which sells low-energy x-ray systems for treating non-melanoma skin cancer and keloids, postponed its IPO on Wednesday. It had filed to raise $20 million by offering 1.8 million shares at a price range of $10 to $12.”  For more information, please visit: http://www.renaissancecapital.com/news/sensing-a-difficult-ipo-market-sensus-healthcare-postpones-%2420-million-ipo-38806.html